Ghazaleh Tabatabai

机构：German Cancer Research Center, University Children's Hospital Tübingen, Bernstein Center for Computational Neuroscience Tübingen, Hertie Institute for Clinical Brain Research, Guided Therapeutics (United States), University of Tübingen · ORCID：0000-0002-3542-8782

发表论文 531 篇 · 总被引 16498 次 · h-index 63

代表论文

• Employing nanopore sequencing on FFPE-derived DNA for CNS tumor diagnostics (2025 · Acta Neuropathologica Communications · 被引 4)
• IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (2026 · Nature Cancer · 被引 1)
• High human cytomegalovirus antigen expression in pediatric medulloblastoma tissue is associated with poor event-free survival (2025 · Neuro-Oncology Advances · 被引 1)
• A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma (2025 · Neuro-Oncology · 被引 1)
• CTIM-15. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: TREATMENT STRATEGY OPTIMIZATION IN THE PHASE 1/2 STUDY EOGBM1-18 / ROSALIE (NCT04116658) (2025 · Neuro-Oncology · 被引 1)
• Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (2026 · Nature Cancer)